NEW YORK & MAINZ, GERMANY--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced positive topline results from a Phase 1/2 study (NCT05596734) evaluating the safety, ...

Thursday, the FDA granted emergency use authorization (EUA) for updated mRNA COVID-19 vaccines (2024-2025 formula) to include a monovalent (single) component that corresponds to the Omicron variant KP ...

Dr. Albert Bourla, chairman and CEO of drugmaker Pfizer, says mRNA technology is "extremely well-tested." - Dia Dipasupil/Getty Images Pharmaceutical rivals don’t often come to each other’s defense.

As your immunity wanes from previous infection and vaccination, the best way to protect yourself against COVID-19 is to get the new COVID vaccine. There are three currently available — is one better ...

Two scientists won the Nobel Prize in medicine for research that laid the groundwork for some of the best-selling medicines of all time: the messenger-RNA vaccines against COVID-19. Katalin Kariko and ...

A slightly disappointing revenue outlook from Pfizer (PFE) was enough for its COVID-19 vaccine rivals Moderna (MRNA) and Novavax (NVAX) to trade lower on Tuesday, just as a major safety scare related ...

The race is on—again. Having already gone up against Moderna in COVID-19 and influenza, Pfizer and BioNTech have now followed their recurring rival in reporting early-phase data on an mRNA combination ...

Stanford researchers identified a two-step immune process causing rare myocarditis after mRNA COVID-19 vaccines, primarily in ...

Expands Pfizer’s access to lipid nanoparticle (LNP) formulation technology, offering a strong strategic fit with Pfizer’s mRNA strategy Pfizer gains option to license Acuitas’ LNP technology for up to ...

The new vaccine program will protect against influenza and COVID-19. Pfizer and BioNtech have announced positive topline data from a vaccine phase 1/2 study (NCT0T05596734), demonstrating immune ...

Moderna and Pfizer are each in the process of competing for federal contracts to build a national stockpile of mRNA vaccines targeted toward the new bird flu amid mounting concerns it may be spreading ...